An epidemiological study of hyperhidrosis

被引:113
作者
Lear, William [1 ]
Kessler, Edward [2 ]
Solish, Nowell [1 ]
Glaser, Dee Anna [2 ]
机构
[1] Womens Coll Hosp, Cosmet Care & Laser Surg Ctr, Toronto, ON M5S 1B2, Canada
[2] St Louis Univ, Sch Med, Anheuser Busch Inst, Dept Dermatol, St Louis, MO USA
关键词
D O I
10.1111/j.1524-4725.2006.32334.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
BACKGROUND Hyperhidrosis affects approximately 3% of the population. The nature of those patients presenting for treatment has not been well studied, however. OBJECTIVE The objective was to perform a descriptive, multicenter study of patterns of patients referred for treatment of focal hyperhidrosis. METHODS AND MATERIALS A convenience sampling of consecutive patients referred for consideration of BTX-A therapy was surveyed. RESULTS A total of 508 patient records (266 patients from Canada; 242 from the United States) were reviewed; 62.8% of those patients were female. The most common presentation was axillary hyperhidrosis in 73.0% of patients. Most of the patients were moderately to severely affected by their hyperhidrosis, with Hyperhidrosis Disease Severity Scale scores of 3 or 4. There were trends found of facial and scalp hyperhidrosis affecting more men than women and being triggered by food much more frequently than in other sites of hyperhidrosis. CONCLUSION This study has demonstrated novel findings, especially in the differing presentations of hyperhidrosis between men and women.
引用
收藏
页码:S69 / S75
页数:7
相关论文
共 11 条
[1]
Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (Botulinum toxin type B) for the treatment of palmar hyperhidrosis [J].
Baumann, L ;
Slezinger, A ;
Halem, M ;
Vujevich, J ;
Mallin, K ;
Charles, C ;
Martin, LK ;
Black, L ;
Bryde, J .
DERMATOLOGIC SURGERY, 2005, 31 (03) :263-270
[2]
Hyperhidrosis: Evolving therapies for a well-established phenomenon [J].
Eisenach, JH ;
Atkinson, JLD ;
Fealey, RD .
MAYO CLINIC PROCEEDINGS, 2005, 80 (05) :657-666
[3]
Effects of gender and level of surgical sympathetic block on vasoconstrictor function [J].
Fronek, KS ;
Schmelz, M ;
Krüger, S ;
Hohenberger, W ;
Schick, CH .
CLINICAL AUTONOMIC RESEARCH, 2003, 13 (Suppl 1) :74-78
[4]
Treatment of hyperhidrosis with botulinum toxin [J].
Glogau, RG .
DERMATOLOGIC CLINICS, 2004, 22 (02) :177-+
[5]
Focal hyperhidrosis: diagnosis and management [J].
Haider, A ;
Solish, N .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (01) :69-75
[6]
Recognition, diagnosis, and treatment of primary focal hyperhidrosis [J].
Hornberger, J ;
Grimes, K ;
Naumann, M ;
Glaser, DA ;
Lowe, NJ ;
Naver, H ;
Ahn, S ;
Stolman, LR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (02) :274-286
[7]
The place of botulinum toxin type A in the treatment of focal hyperhidrosis [J].
Lowe, N ;
Campanati, A ;
Bodokh, I ;
Cliff, S ;
Jaen, P ;
Kreyden, O ;
Naumann, M ;
Offidani, A ;
Vadoud, J ;
Hamm, H .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (06) :1115-1122
[8]
Treatment of axillary hyperhidrosis [J].
Naumann, M ;
Hamm, H .
BRITISH JOURNAL OF SURGERY, 2002, 89 (03) :259-261
[9]
Palmar hyperhidrosis: Evidence of genetic transmission [J].
Ro, KM ;
Cantor, RM ;
Lange, KL ;
Ahn, SS .
JOURNAL OF VASCULAR SURGERY, 2002, 35 (02) :382-386
[10]
Differential effects of surgical sympathetic block on sudomotor and vasoconstrictor function [J].
Schick, CH ;
Fronek, K ;
Held, A ;
Birklein, F ;
Hohenberger, W ;
Schmelz, M .
NEUROLOGY, 2003, 60 (11) :1770-1776